Activated AMPK inhibits PPAR-α and PPAR-γ transcriptional activity in hepatoma cells

MS Sozio, C Lu, Y Zeng… - American Journal of …, 2011 - journals.physiology.org
MS Sozio, C Lu, Y Zeng, S Liangpunsakul, DW Crabb
American Journal of Physiology-Gastrointestinal and Liver …, 2011journals.physiology.org
AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-α
(PPAR-α) are critical regulators of short-term and long-term fatty acid oxidation, respectively.
We examined whether the activities of these molecules were coordinately regulated.
H4IIEC3 cells were transfected with PPAR-α and PPAR-γ expression plasmids and a
peroxisome-proliferator-response element (PPRE) luciferase reporter plasmid. The cells
were treated with PPAR agonists (WY-14,643 and rosiglitazone), AMPK activators 5 …
AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-α (PPAR-α) are critical regulators of short-term and long-term fatty acid oxidation, respectively. We examined whether the activities of these molecules were coordinately regulated. H4IIEC3 cells were transfected with PPAR-α and PPAR-γ expression plasmids and a peroxisome-proliferator-response element (PPRE) luciferase reporter plasmid. The cells were treated with PPAR agonists (WY-14,643 and rosiglitazone), AMPK activators 5-aminoimidazole-4-carboxamide riboside (AICAR) and metformin, and the AMPK inhibitor compound C. Both AICAR and metformin decreased basal and WY-14,643-stimulated PPAR-α activity; compound C increased agonist-stimulated reporter activity and partially reversed the effect of the AMPK activators. Similar effects on PPAR-γ were seen, with both AICAR and metformin inhibiting PPRE reporter activity. Compound C increased basal PPAR-γ activity and rosiglitazone-stimulated activity. In contrast, retinoic acid receptor-α (RAR-α), another nuclear receptor that dimerizes with retinoid X receptor (RXR), was largely unaffected by the AMPK activators. Compound C modestly increased AM580 (an RAR agonist)-stimulated activity. The AMPK activators did not affect PPAR-α binding to DNA, and there was no consistent correlation between effects of the AMPK activators and inhibitor on PPAR and the nuclear localization of AMPK-α subunits. Expression of either a constitutively active or dominant negative AMPK-α inhibited basal and WY-14,643-stimulated PPAR-α activity and basal and rosiglitazone-stimulated PPAR-γ activity. We concluded that the AMPK activators AICAR and metformin inhibited transcriptional activities of PPAR-α and PPAR-γ, whereas inhibition of AMPK with compound C activated both PPARs. The effects of AMPK do not appear to be mediated through effects on RXR or on PPAR/RXR binding to DNA. These effects are independent of kinase activity and instead appear to rely on the activated conformation of AMPK. AMPK inhibition of PPAR-α and -γ may allow for short-term processes to increase energy generation before the cells devote resources to increasing their capacity for fatty acid oxidation.
American Physiological Society